Novo Nordisk Recalls Norditropin Pens Due to Delivery Fault
Novo Nordisk recalls 723 Norditropin FlexPro pens due to a defective delivery system that may block during use. Check lot FC70222.
Use caution until it’s fixed
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step
Contact the company
What happened, in plain English
Novo Nordisk Inc. is recalling 723 units of the Norditropin FlexPro Somatropin injection pen because the delivery system may be defective. This defect can cause the pen to block during the 'air shot' step, potentially preventing proper medication delivery. The recall affects pens distributed nationwide. Read more at govinfonow.com/recall/42860-novo-nordisk-recalls-norditropin-pens-due-to-delivery-fault.
Source Summary by GovInfoNow · govinfonow.com/recall/42860-novo-nordisk-recalls-norditropin-pens-due-to-delivery-fault · Updated October 9, 2026 · FDA enforcement record: FDA #D-0956-2016
Cite this page
“Novo Nordisk Recalls Norditropin Pens Due to Delivery Fault.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42860-novo-nordisk-recalls-norditropin-pens-due-to-delivery-fault. Based on FDA recall #D-0956-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0956-2016%22&limit=1).
Why it’s dangerous
The pens have a low frequency assembly fault in the delivery system. This defect may cause the pen to block during the 'air shot' step, which is a critical part of ensuring the device works correctly before injection.
Who’s affected
Patients prescribed Norditropin FlexPro Somatropin who purchased or were dispensed the specific recalled lot are affected. These individuals rely on the device for accurate medication dosing.
How to tell if you have this one
Check if you have a Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen. Specifically look for NDC 0169-7703-21 and Lot Number FC70222.
- Brand
Novo Nordisk- Category
Drug
What to do — step by step
Check Your Lot Number
Verify if your pen matches the recalled lot number FC70222 and NDC 0169-7703-21.
Contact Healthcare Provider
Speak with your doctor or pharmacist to determine how to proceed with your treatment given the potential delivery issue.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0956-2016 (April 27, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0956-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.